These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 20148887

  • 21. [Cost-per-responder analysis comparing romiplostim to rituximab in the treatment of adult primary immune thrombocytopenia in Spain].
    López MF, Mingot ME, Valcárcel D, Vicente García V, Perrin A, Campos Tapias I.
    Med Clin (Barc); 2015 May 08; 144(9):389-96. PubMed ID: 24565604
    [Abstract] [Full Text] [Related]

  • 22. Effectiveness of thrombopoietin-receptor agonists in the treatment of refractory immune thrombocytopenia associated to systemic lupus erythematosus.
    Magnano L, Enríquez H, Esteve J, Cervera R, Espinosa G.
    J Rheumatol; 2014 Sep 08; 41(9):1895-6. PubMed ID: 25179983
    [No Abstract] [Full Text] [Related]

  • 23. Thrombopoietin receptor agonists in immune thrombocytopenia of less than 6 months duration.
    Arumugaswamy A, He S, Quach H, Brotchie J, Grigg A.
    Intern Med J; 2014 May 08; 44(5):519-21. PubMed ID: 24816314
    [No Abstract] [Full Text] [Related]

  • 24. Romiplostim in children with immune thrombocytopenia: a phase 3, randomised, double-blind, placebo-controlled study.
    Tarantino MD, Bussel JB, Blanchette VS, Despotovic J, Bennett C, Raj A, Williams B, Beam D, Morales J, Rose MJ, Carpenter N, Nie K, Eisen M.
    Lancet; 2016 Jul 02; 388(10039):45-54. PubMed ID: 27103127
    [Abstract] [Full Text] [Related]

  • 25. [Romplostim in the treatment of immune thrombocytopenic purpura at a tertiary hospital].
    Riu Viladoms G, Creus Baró N, Estefanell Tejero A, Ribas Sala J.
    Farm Hosp; 2012 Jul 02; 36(5):434-7. PubMed ID: 22871365
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Romiplostim as an early treatment for refractory immune thrombocytopenia in a 2-month-old infant.
    Chiba Y, Tasaka K, Matsubara K, Mori M, Muraoka M, Hamabata T, Nodomi S, Waki K.
    Pediatr Blood Cancer; 2024 Jun 02; 71(6):e30953. PubMed ID: 38520052
    [No Abstract] [Full Text] [Related]

  • 29. Response of refractory immune thrombocytopenia after bone marrow transplantation to romiplostim.
    Beck JC, Burke MJ, Tolar J.
    Pediatr Blood Cancer; 2010 Mar 02; 54(3):490-1. PubMed ID: 19908296
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Romiplostim for management of refractory immune thrombocytopenic purpura in the immediate postpartum period.
    Patras A, Figueroa R, Singh AP, Madan I.
    BMJ Case Rep; 2020 May 18; 13(5):. PubMed ID: 32430352
    [Abstract] [Full Text] [Related]

  • 34. New synergistic efficacy of combination of romiplostim and steroid in refractory immune thrombocytopenia patients.
    Yoon JS, Lee YJ, Baek DW, Park HY, Park BE, Moon JH, Sohn SK.
    Korean J Intern Med; 2018 Mar 18; 33(2):435-437. PubMed ID: 26947025
    [No Abstract] [Full Text] [Related]

  • 35. Romiplostim for the treatment of glioblastoma-related paraneoplastic autoimmune thrombocytopenia refractory to conventional therapy.
    Rodríguez-Lobato LG, Martinez-Cibrian N, Fernández-Avilés F, Gaya A, Pineda-Losada E, Esteve J.
    Ann Hematol; 2016 Mar 18; 95(4):665-6. PubMed ID: 26787417
    [No Abstract] [Full Text] [Related]

  • 36. Eltrombopag. Idiopathic thrombocytopenic purpura after treatment failure: romiplostim is a better option.
    Prescrire Int; 2010 Feb 18; 19(105):15. PubMed ID: 20455333
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Development of thrombopoietin receptor agonists].
    Miyakawa Y.
    Rinsho Ketsueki; 2009 Oct 18; 50(10):1434-43. PubMed ID: 19915352
    [No Abstract] [Full Text] [Related]

  • 39. [Management of refractory ITP with thrombopoietin receptor agonists].
    Tomiyama Y.
    Rinsho Ketsueki; 2011 Aug 18; 52(8):627-32. PubMed ID: 21897068
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.